JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
![Foto de JAVIER](/img/uploaded/B1C208A8E1820F13282153D4BA39B96E.jpg)
![Foto de Duke University](/img/noimage_org.png)
Duke University
Durham, Estados UnidosPublications in collaboration with researchers from Duke University (16)
2024
2023
-
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
Journal of the American College of Cardiology, Vol. 82, Núm. 8, pp. 687-700
-
Differential predictability for high-risk plaque characteristics between fractional flow reserve and instantaneous wave-free ratio
Scientific Reports, Vol. 13, Núm. 1
-
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions, Vol. 16, Núm. 20, pp. 2514-2524
2022
-
Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction
Journal of the American Heart Association, Vol. 11, Núm. 15, pp. e025841
-
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 17, Núm. 16, pp. 1330-1339
-
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 11, pp. e897-e909
2021
-
Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: Study protocol of the randomised controlled iMODERN trial
BMJ Open, Vol. 11, Núm. 1
-
Sex Differences among Patients with High Risk Receiving Ticagrelor with or without Aspirin after Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial
JAMA Cardiology, Vol. 6, Núm. 9, pp. 1032-1041
2020
-
Ticagrelor alone vs.Ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
European Heart Journal, Vol. 41, Núm. 37, pp. 3533-3545
2019
-
Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
Journal of the American College of Cardiology, Vol. 73, Núm. 4, pp. 444-453
-
Comparison of Major Adverse Cardiac Events between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients with or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiology, Vol. 4, Núm. 9, pp. 857-864
-
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
JACC: Cardiovascular Interventions, Vol. 12, Núm. 20, pp. 2035-2046
-
Ticagrelor with or without aspirin in high-risk patients after PCI
New England Journal of Medicine, Vol. 381, Núm. 21, pp. 2032-2042
2018
-
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
JACC: Cardiovascular Interventions, Vol. 11, Núm. 15, pp. 1437-1449
2017
-
Use of the instantaneous wave-free ratio or fractional flow reserve in PCI
New England Journal of Medicine, Vol. 376, Núm. 19, pp. 1824-1834